OMER Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.90%

Insider Buying (Last 12 Months): $40,500.00

Insider Selling (Last 12 Months): $32,300.00

Omeros Insider Trading History Chart

Omeros Share Price & Price History

^$3.15

▲ +0.09 (2.94%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Omeros Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2023	Gregory A. Demopulos	CEO	Buy	15,000	$1.68	$25,200.00	123,945
11/15/2023	Peter A Md Demopulos	Director	Buy	10,000	$1.53	$15,300.00	208,516
5/22/2023	Arnold C. Hanish	Director	Sell	5,000	$6.46	$32,300.00	35,067
6/17/2021	Gregory A. Demopulos	CEO	Sell	36,857	$14.90	$549,169.30	2,063,842
6/15/2021	Gregory A. Demopulos	CEO	Sell	36,856	$15.02	$553,577.12	2,063,842

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Omeros (NASDAQ:OMER)

48.79% of Omeros stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Omeros Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/27/2024	Nomura Holdings Inc.	383,144	$1.25M	0.0%	-14.0%	0.609%
2/13/2024	Tower Research Capital LLC TRC	8,069	$26K	0.0%	+199.9%	0.013%
2/12/2024	Stifel Financial Corp	1,890,674	$6.18M	0.0%	-6.8%	3.007%
2/9/2024	Hohimer Wealth Management LLC	22,530	$74K	0.0%	-57.1%	0.036%
2/9/2024	Corient Private Wealth LLC	663,663	$2.17M	0.0%	-3.4%	1.056%
2/9/2024	Coldstream Capital Management Inc.	28,130	$92K	0.0%	+42.1%	0.045%
2/6/2024	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	30,000	$98K	0.0%	+200.0%	0.048%
2/5/2024	Brighton Jones LLC	33,516	$0.11M	0.0%	-29.5%	0.053%
1/26/2024	Cerity Partners LLC	21,850	$71K	0.0%	N/A	0.035%
1/24/2024	Rocky Mountain Advisers LLC	26,800	$88K	0.0%	-20.0%	0.043%
1/16/2024	Raymond James & Associates	10,925	$36K	0.0%	-75.4%	0.017%
1/12/2024	SG Americas Securities LLC	30,438	$100K	0.0%	+59.3%	0.048%
11/14/2023	Ancora Advisors LLC	210,023	$0.61M	0.0%	+23.1%	0.334%
11/14/2023	Nomura Holdings Inc.	445,482	$1.30M	0.0%	-28.3%	0.709%
11/13/2023	Stifel Financial Corp	2,027,917	$5.92M	0.0%	-1.4%	3.226%
11/7/2023	Barclays PLC	45,629	$0.13M	0.0%	+51.2%	0.073%
11/1/2023	Jacob Asset Management of New York LLC	55,168	$0.16M	0.2%	-31.2%	0.088%
10/13/2023	SG Americas Securities LLC	19,105	$56K	0.0%	N/A	0.030%
9/21/2023	Barclays PLC	30,173	$0.16M	0.0%	-62.5%	0.048%
9/12/2023	Farther Finance Advisors LLC	6,000	$33K	0.0%	N/A	0.010%
8/10/2023	Jacob Asset Management of New York LLC	80,168	$0.44M	0.5%	-16.6%	0.128%
8/10/2023	Cetera Advisors LLC	88,365	$0.48M	0.0%	N/A	0.141%
8/4/2023	American International Group Inc.	29,302	$0.16M	0.0%	N/A	0.047%
8/2/2023	Bank of Montreal Can	563,297	$3.40M	0.0%	N/A	0.897%
7/25/2023	Raymond James & Associates	44,718	$0.24M	0.0%	-25.2%	0.071%
7/13/2023	Cambridge Investment Research Advisors Inc.	47,430	$0.26M	0.0%	-13.1%	0.075%
7/6/2023	Apella Capital LLC	14,288	$78K	0.0%	N/A	0.023%
5/11/2023	Jacob Asset Management of New York LLC	96,168	$0.45M	0.5%	+11.6%	0.153%
5/8/2023	Brighton Jones LLC	54,517	$0.25M	0.0%	-12.5%	0.087%
5/4/2023	Barclays PLC	80,406	$0.37M	0.0%	+167.5%	0.128%
5/4/2023	Cypress Capital Group	50,000	$0.23M	0.0%	-9.1%	0.080%
5/1/2023	Sheaff Brock Investment Advisors LLC	60,125	$0.28M	0.0%	-4.8%	0.096%
4/14/2023	Raymond James & Associates	59,818	$0.28M	0.0%	-58.5%	0.095%
2/8/2023	Cambridge Investment Research Advisors Inc.	55,087	$0.12M	0.0%	+46.9%	0.088%
2/1/2023	Bank of Montreal Can	563,095	$1.53M	0.0%	-0.7%	0.898%
2/1/2023	Hohimer Wealth Management LLC	52,530	$0.12M	0.0%	+33.7%	0.084%
1/27/2023	Denver Wealth Management Inc.	46,581	$0.11M	0.1%	N/A	0.074%
1/10/2023	Coldstream Capital Management Inc.	17,795	$40K	0.0%	N/A	0.028%
11/14/2022	Cubist Systematic Strategies LLC	204,122	$0.64M	0.0%	+806.0%	0.325%
11/10/2022	UBS Group AG	652,743	$2.06M	0.0%	-3.3%	1.041%
11/9/2022	Brighton Jones LLC	53,540	$0.17M	0.0%	+233.7%	0.085%
11/4/2022	Cypress Capital Group	45,000	$0.14M	0.0%	-39.2%	0.072%
11/3/2022	Sonora Investment Management Group LLC	10,375	$29K	0.0%	-99.8%	0.017%
10/27/2022	Lesa Sroufe & Co	17,735	$56K	0.1%	N/A	0.028%
10/26/2022	Belvedere Trading LLC	54,136	$0.19M	0.0%	-27.9%	0.086%
10/25/2022	Raymond James & Associates	103,518	$0.33M	0.0%	-34.9%	0.165%
8/15/2022	Laurion Capital Management LP	17,897	$49K	0.0%	N/A	0.029%
8/13/2022	Ronald Blue Trust Inc.	5,000	$30K	0.0%	N/A	0.008%
8/11/2022	Denver Wealth Management Inc.	41,671	$0.12M	0.1%	N/A	0.066%
8/4/2022	Brighton Jones LLC	16,042	$44K	0.0%	-58.9%	0.026%
8/3/2022	DDD Partners LLC	11,131	$31K	0.0%	N/A	0.018%
8/2/2022	Sheaff Brock Investment Advisors LLC	57,580	$0.16M	0.0%	+16.1%	0.092%
8/2/2022	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	10,000	$28K	0.0%	N/A	0.016%
7/26/2022	Cypress Capital Group	74,000	$0.20M	0.0%	+100.0%	0.118%
7/13/2022	Cambridge Investment Research Advisors Inc.	37,487	$0.10M	0.0%	+33.7%	0.060%
5/12/2022	Jacob Asset Management of New York LLC	114,910	$0.69M	0.4%	-30.7%	0.183%
5/11/2022	Roanoke Asset Management Corp NY	12,000	$72K	0.0%	N/A	0.019%
5/6/2022	Quad Cities Investment Group LLC	10,200	$61K	0.0%	N/A	0.016%
5/3/2022	Hohimer Wealth Management LLC	39,280	$0.24M	0.0%	-20.3%	0.063%
5/2/2022	National Asset Management Inc.	15,568	$94K	0.0%	-17.2%	0.025%
2/14/2022	Opti Capital Management LP	6,100,000	$5.60M	0.4%	-53.8%	9.753%
2/14/2022	GSA Capital Partners LLP	45,308	$0.29M	0.0%	-29.0%	0.072%
2/11/2022	Ensign Peak Advisors Inc	19,360	$0.12M	0.0%	N/A	0.031%
2/10/2022	Rafferty Asset Management LLC	16,149	$0.10M	0.0%	N/A	0.026%
2/10/2022	Teacher Retirement System of Texas	11,412	$73K	0.0%	N/A	0.018%
2/9/2022	Principal Financial Group Inc.	10,255	$66K	0.0%	-58.8%	0.016%
2/9/2022	BNP Paribas Arbitrage SA	146,011	$0.94M	0.0%	+1,254.1%	0.233%
2/9/2022	Jacob Asset Management of New York LLC	165,923	$1.07M	0.5%	-49.4%	0.265%
2/9/2022	Rocky Mountain Advisers LLC	36,405	$0.23M	0.3%	+68.3%	0.058%
2/9/2022	Baird Financial Group Inc.	27,100	$0.17M	0.0%	+68.3%	0.043%
2/8/2022	Raymond James Financial Services Advisors Inc.	14,068	$90K	0.0%	N/A	0.022%
2/8/2022	Bank of America Corp DE	324,931	$2.09M	0.0%	+110.9%	0.520%
2/8/2022	Raymond James & Associates	137,818	$0.89M	0.0%	-23.7%	0.220%
2/8/2022	Northern Trust Corp	671,750	$4.32M	0.0%	-2.9%	1.074%
2/7/2022	SG Americas Securities LLC	15,608	$100K	0.0%	-48.1%	0.025%
2/3/2022	Cambridge Investment Research Advisors Inc.	34,584	$0.22M	0.0%	-13.1%	0.055%
2/3/2022	Advisor Group Holdings Inc.	10,415	$67K	0.0%	+97.3%	0.017%
2/3/2022	Sheaff Brock Investment Advisors LLC	47,580	$0.31M	0.0%	+8.6%	0.076%
2/3/2022	Brighton Jones LLC	41,503	$0.27M	0.0%	-62.2%	0.066%
2/3/2022	Bellevue Asset Management LLC	15,811	$0.10M	0.1%	+43.6%	0.025%
1/28/2022	Woodward Diversified Capital LLC	14,800	$95K	0.1%	-86.7%	0.024%
1/26/2022	Creative Financial Designs Inc. ADV	8,750	$56K	0.0%	+29.6%	0.014%
1/25/2022	Hohimer Wealth Management LLC	49,280	$0.32M	0.1%	+18.5%	0.079%
1/21/2022	Denali Advisors LLC	7,100	$46K	0.0%	N/A	0.011%
1/18/2022	CAPROCK Group Inc.	60,812	$0.39M	0.0%	+8.6%	0.097%
1/13/2022	Apella Capital LLC	14,288	$92K	0.0%	N/A	0.023%
11/16/2021	Schonfeld Strategic Advisors LLC	15,182	$0.21M	0.0%	-23.3%	0.024%
11/16/2021	Two Sigma Advisers LP	168,700	$2.33M	0.0%	+27.9%	0.270%
11/16/2021	Two Sigma Investments LP	221,799	$3.06M	0.0%	-43.9%	0.355%
11/16/2021	UBS Group AG	523,813	$7.22M	0.0%	+7.4%	0.838%
11/16/2021	United Capital Financial Advisers LLC	104,223	$1.44M	0.0%	-1.9%	0.167%
11/16/2021	Voloridge Investment Management LLC	93,649	$1.29M	0.0%	-51.5%	0.150%
11/16/2021	Millennium Management LLC	192,242	$2.65M	0.0%	-43.6%	0.307%
11/16/2021	Bain Capital Public Equity Management II LLC	400,072	$5.52M	0.2%	-6.0%	0.640%
11/15/2021	Cubist Systematic Strategies LLC	43,117	$0.60M	0.0%	-19.8%	0.069%
11/15/2021	California State Teachers Retirement System	81,036	$1.12M	0.0%	-2.5%	0.130%
11/15/2021	Tudor Investment Corp Et Al	35,756	$0.49M	0.0%	N/A	0.057%
11/15/2021	Royal Bank of Canada	603,632	$8.32M	0.0%	-2.4%	0.965%
11/15/2021	Virtus ETF Advisers LLC	29,436	$0.41M	0.2%	-8.4%	0.047%
11/15/2021	GSA Capital Partners LLP	63,770	$0.88M	0.1%	-46.8%	0.102%

Data available starting January 2016

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that is in phase Ib clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders; and OMS405 that is in phase II clinical trials for opioid and nicotine addiction. In addition, the company develops MASP-2-small-molecule inhibitors for the treatment of aHUS, HSCT-TMA, and age-related macular degeneration; GPR174 inhibitors and chimeric antigen receptor T-Cell and adoptive T-Cell therapies for various cancers; and G protein-coupled receptors for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.

Today's Range

Now: $3.15

$3.07

$3.18

50 Day Range

MA: $3.75

$3.04

$4.89

52 Week Range

Now: $3.15

$0.92

$7.80

Volume

172,888 shs

Average Volume

391,732 shs

Market Capitalization

$182.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Omeros?: Omeros' top insider shareholders include:
Peter A Md Demopulos (Director)
Gregory A Md Demopulos (CEO)
Arnold C Hanish (Director)
Learn More about top insider investors at Omeros.
Who are the major institutional investors of Omeros?: Omeros' top institutional investors include:
Simplex Trading LLC — 0.00%
Learn More about top institutional investors of Omeros stock.
Which institutional investors are buying Omeros stock?: Within the last quarter, OMER stock was purchased by institutional investors including:
Simplex Trading LLC
During the last year, these company insiders have bought Omeros stock:
Peter A Md Demopulos (Director)
Gregory A Md Demopulos (CEO)
Learn More investors buying Omeros stock.